🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study evaluates the efficacy and safety of ombitasvir/paritaprevir/rit...
Status
Completed
Location
Multiple Locations
Start Date
2015-09-30
Trial ID
NCT02487199
Treatments Being Tested
SHARP-P is an observational cohort study investigating the effect of direct...
Status
Completed
Location
NSW Correctional Centres
Start Date
2019-09-06
Trial ID
NCT03740906
This study was to assess whether sofosbuvir in combination with ribavirin (...
Status
Completed
Location
University of Alabama Birmingham
Start Date
2012-06
Trial ID
NCT01641640
Treatments Being Tested
SHARP-C is an observational cohort study investigating the effect of direct...
Status
Completed
Location
St Vincent's Hospital
Start Date
2018-08-17
Trial ID
NCT03343925
This phase 2b study will evaluate the efficacy and safety of 16 and 24 week...
Status
Completed
Location
Mayo Clinic
Start Date
2010-10
Trial ID
NCT01225380
The primary objectives of this study are to evaluate the efficacy, safety, ...
Status
Completed
Location
National Cancer Institute, Cairo University
Start Date
2016-08-28
Trial ID
NCT02868242
Treatments Being Tested
The purpose of this study was to assess the efficacy of a fixed dose combin...
Status
Completed
Location
Ucsd, Avrc Crs (701)
Start Date
2019-11-20
Trial ID
NCT04042740
Treatments Being Tested
The purpose of this study is to evaluate the feasibility of rapid scale-up ...
Status
Unknown
Location
Dr Doong's Surgery
Start Date
2014-07
Trial ID
NCT02102451
The investigators assessed non-organ-specific antibodies before and 24 week...
Status
Completed
Location
Policlinic Hospital
Start Date
2015-07-01
Trial ID
NCT03566966
Treatments Being Tested
This study will integrate mobile hepatitis C virus (HCV) testing and treatm...
Status
Unknown
Location
Mobile Study Van
Start Date
2022-05-18
Trial ID
NCT05466331
Treatments Being Tested